ALLA BOYCHUK

ALLA BOYCHUK

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SKSolomiia Kramar
Solomiia Kramar
ZNZoia Nebesna
Zoia Nebesna
YYYuliya Yakymchuk
Yuliya Yakymchuk
ABALLA BOYCHUK
ALLA BOYCHUK
OSOksana Shevchuk
Oksana Shevchuk
SVSandor George Vari
Sandor George Vari
SARS-CoV-2 infection in pregnant women can lead to pregnancy-related complications. This work aims to study the spectrum of pathological changes in the placentas of SARS-CoV-2-infected pregnant women. The study involved 50 pregnant women with COVID-19 disease in the first (group I), second (group II), and third (group III) trimesters. Placental sections were examined by histopathology, electron microscopy, and immunohistochemistry to assess structural and molecular changes. The placentas of SARS-CoV-2-affected pregnant women exhibit nonspecific pathological changes, primarily associated with impaired blood circulation. The most frequent findings include thrombosis, chorangiosis, villous edema, and fibrinoid necrosis, all indicative of endothelial dysfunction. Increased expression of sclerostin and Annexin A2 was also detected in affected placentas. The main submicroscopic manifestations of placental insufficiency in COVID-19-affected women are dystrophic–destructive changes in the stroma of the villi, manifested by edema and fibrous processes, which cause significant disruption of the fetoplacental barrier. SARS-CoV-2 causes thrombotic and sclerotic changes, mainly in the maternal portion of the placenta. The manifestation of pathological changes in the placenta of COVID-19-affected women depends on the pregnancy period during which infection by SARS-CoV-2 has occurred. The established findings may provide insights into the connection between COVID-19 in pregnancy and antenatal and perinatal outcomes.

25 October 2022 in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Verified
Journal Article
Open access
PDF file
ABALLA BOYCHUK
ALLA BOYCHUK
TBT.O. Budnik
T.O. Budnik
Background. Vitamin D deficiency is recognized as a global health problem, affecting approximately one billion people of all ages worldwide. Although maternal vitamin D deficiency is a significant health concern, there are not enough studies in Ukraine that confirm the relationship between vitamin D levels and adverse pregnancy outcomes. At the same time, it is necessary to emphasize the importance of screening the level of vitamin D as one of the routine tests in the early stages of pregnancy, which will contribute to the prevention of disorders during pregnancy. The purpose of this study is to determine the content of vitaminD in pregnant women and establish its effect on pregnancy and maternal outcomes. Materials and methods. Ninety pregnant women were under observation, they were selected according to the inclusion criteria: pregnancy period over 28 weeks, no vitamin D intake during pregnancy. Depending on 25(OH)D serum level, pregnant women were divided into three groups. The first group included 30 patients with vitamin D deficiency of 25(OH)D level less than 20 ng/ml, the second group included 35 pregnant women with vitamin D insufficiency, 25(OH)D level of 20–29.9ng/ml. Women with normal 25(OH)D levels (>30ng/ml) formed the third research group (n=25). Results. Among extragenital pathologies, diseases of the gastrointestinal tract were observed almost three times more often with vitaminD deficiency than with its insufficiency, and turned out to be a significant factor for the development of vitamin D deficiency (odds ratio 3.02; 95% confidence interval: 1.16–10.4; p<0.05). It was found that in pregnant women of the first group, vitamin D deficiency is a risk factor for diseases of the musculoskeletal system (odds ratio 4.38; 95% confidence interval: 1.11–25.8; p<0.05). Eight women (26.7%) from the first group were diagnosed with gestational diabetes by conducting a glucose tolerance test (at 26–28 weeks of pregnancy). At the same time, gestational diabetes was diagnosed against the background of obesity class I–II. Maternal vitaminD deficiency is reliably associated with a high risk of cesarean section and the presence of complications during pregnancy and childbirth. Conclusions. The conducted study shows the negative impact of low levels of 25(ОН)D on the course and consequences of pregnancy.

29 December 2023 in Reproductive Endocrinology
Verified
Journal Article
Open access
PDF file
ABALLA BOYCHUK
ALLA BOYCHUK
DHD.G. Herman
D.G. Herman
YDY.O. Dubossarska
Y.O. Dubossarska
NZN.F. Zakharenko
N.F. Zakharenko
LKL.V. Kalugina
L.V. Kalugina
NYN.V. Yarotska
N.V. Yarotska
Endometriosis affects 10% of all women of reproductive age, i.e. 190 million patients. Ukraine currently does not gather statistics on the incidence of endometriosis, but, at a rough estimate, this number is approximately 280 thousand women and the real number may be higher. Endometriosis has known significant social, medical and economic impact. Therefore, Ukrainian leading specialists in obstetrics and gynecology focus on new treatments for endometriosis, given current scientific data and the needs of patients. The given resolution and algorithms for treatment for endometriosis are the common stand of leading specialists in gynecology in our country and were developed on the basis of modern domestic and foreign data and current clinical guidelines. This resolution aims to improve clinical approaches to the routine practice of treatment for endometriosis. The constant increase in the incidence of endometriosis and its management characteristics allows to conduct an extensive study of the effectiveness and safety profile of various progestogens. In recent years, a number of further evidence have appeared regarding dydrogesterone treatment for endometriosis. New data on the effectiveness of dydrogesterone offer another hormone-based treatment for endometriosis, which is extremely important given the need for long-term and individualized treatment for endometriosis.The Europ ean Society of Human Reproduction and Embryology (ESHRE) states that the degree of pain relief in endometriosis is the same for all hormone-based treatments, but the safety and tolerability profiles of different medicinal products differ, which must be considered. According to the obtained data on the effectiveness and metabolic safety profile of various progestogens and during the discussion, algorithms for dydrogesterone-based treatment for endometriosis were proposed.

9 September 2021 in Актуальні питання педіатрії, акушерства та гінекології
Verified
Journal Article
Open access
PDF file
ABALLA BOYCHUK
ALLA BOYCHUK
ОХО. І. Хлібовська
О. І. Хлібовська
ВШВ. С. Шадріна
В. С. Шадріна
YYYuliya Yakymchuk
Yuliya Yakymchuk
Мета дослідження – вивчення перебігу вагітності, ускладнень, які виникають у вагітних жінок та внутрішньоутробного плода після перенесеного COVID-19, його впливу на виношування вагітності, родорозрішення та стан новонародженого. Матеріали та методи. У статті висвітлено особливості перебігу вагітності та пологів у 142 вагітних, які перенесли СОВІД-19 при вагітності. Результати дослідження та їх обговорення. Доведено негативний вплив перенесеного СОВІД-19 на перебіг вагітності, яких був ускладнений фетоплацентарною дисфункцією. З метою корекції виявлених порушень розроблено комплексну терапію, яка сприяла покращенню матково-плацентарного кровообігу. Висновки. Перенесений COVID-19 у легкій формі у вагітних жінок спричиняє ускладнення перебігу вагітності через патологічний кровотік у судинах малого таза та матки. Своєчасна діагностика порушень внутрішньоутробного стану плода та призначення антиагрегантної терапії позитивно впливають на перебіг вагітності та пологів.

20 March 2023 in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Verified
Journal Article
Open access
PDF file
TBT.O. Budnik
T.O. Budnik
ABALLA BOYCHUK
ALLA BOYCHUK
Background. The prevalence of vitamin D deficiency appears to be increasing worldwide. Pregnant women are at risk of developing vitamin D deficiency. Vitamin D status has a great impact on both pregnancy and the fetus. Vitamin D deficiency during pregnancy has been associated with several adverse pregnancy outcomes. The purpose of the study was to evaluate serum vitamin D level during the first trimester of pregnancy and its effect on the neonatal anthropometric measures. Material and methods. A prospective study among 71 pregnant women aged 19 to 42 years in the first trimester was carried out between October 2018 to April 2020. A survey of pregnant women (socio-demographic characteristics, anamnestic data and diet) was conducted, and the maternal serum total vitamin D level was determined by enzyme immunoassay. Neonatal anthropometric parameters (weight, body length, weight/length ratio) were measured. Results. Vitamin D deficiency was observed in 41 (57.7%) of pregnant women, insufficiency in 7 (9.9%), and the optimal level in 23 (32.4%) of examined women. Women with vitamin D deficiency were more likely to have a history of miscarriage than those with optimal D status (odds ratio 9.06, 95% confidence interval 1.11–73.86, Р=0.0396). We have not found the influence of other factors (age, social status, body mass index, number of pregnancies) on the maternal vitamin D level. There were no significant differences between indicators of weight by age, body length of a child by age, and Apgar scores depending on the vitaminD levels of pregnant women. Conclusions. The study showed that the optimal vitamin D level is observed only in 32.4% of cases, and its deficiency or insufficiency occurs in 67.6% of pregnant women in the first trimester. The study did not reveal the correlation between maternal vitamin D level during the first trimester of pregnancy and neonatal anthropometric measures. Given the trend towards lower weight/length ratio to gestational age of the newborns from mothers with vitamin D deficiency, further studies are needed.

29 March 2024 in Reproductive health of woman
Verified
Journal Article
Open access
PDF file
NKN.V. Kotsabyn
N.V. Kotsabyn
ABALLA BOYCHUK
ALLA BOYCHUK
YYYu.B. Yakymchuk
Yu.B. Yakymchuk
OYO.M. Yakymchuk
O.M. Yakymchuk
YYYuliya Yakymchuk
Yuliya Yakymchuk
Hysteroscopy is considered the “gold standard” for endoscopic visualization of the uterine cavity. Various methods of anesthesia and analgesia for the hysteroscopy procedure are described, including general anesthesia, sedation, local anesthesia, oral analgesics, and inhalation anesthesia.The objective: to assess the use of inhalation sedation with methoxyflurane during office hysteroscopy.Materials and methods. A prospective clinical study was performed in 109 patients during 2022-2024 who admitted to the reproductive health center “Damia” for the treatment of infertility. During office hysteroscopy, all patients had examination of the uterine cavity and biopsy of the endometrium with forceps.I group included 57 women who were prescribed rectal ketoprofen 100 mg and per os paracetamol 500 mg as analgesia during hysteroscopy in outpatient settings; II group involved 52 patients who received methoxyflurane for analgesia through an individual device for inhalation use.The Spielberger–Hanin scale was used to determine the levels of personal and reactive anxiety; assessment of psychoemotional status for the study of depressive disorders was carried out using the Beck depression scale and determination of the effectiveness of analgesic therapy. Statistical processing of the research results was performed using the program “STATISTICA 10”.Results. The spread of chronic endometritis, which was diagnosed for the first time, was established in more than half of the patients (56.9%). When using methoxyflurane for analgesia by the inhalation method, the examined patients subjectively assessed the pain at a rather low level (0.14±0.05 points), and the intensity of pain in the I group was significantly higher (0.41±0.08 points; p=0.005).In the postoperative period in the patients of the I group there were significantly higher levels of depressive disorders (7.84±0.86 points vs 4.54±0.62 points in the II group; p=0.002), personal (27.12±2.32 points vs 19.64±2.04 points; p=0.017) and situational (21.92±2.14 vs 15.56±1.72 points; p=0.022) anxiety, a reduced level of mood and emotionality, which differed from the indicators of women of the II group. Among the most frequent complaints in the I group, dyspeptic disorders (31.6%) and pain in the epigastric area (21.05%) were observed. When using methoxyflurane, the most frequent complaints were headache and drowsiness (11.5% each).Conclusions. The use of inhalation anesthesia with methoxyflurane during hysteroscopy allows to reduce negative pain sensations, anxiety and can be the optimal method for anesthesia for its performance in outpatient conditions.